Literature DB >> 11929667

Validation of a near-infrared transmission spectroscopic procedure, part A: validation protocols.

Howard Mark1, Gary E Ritchie, Robert W Roller, Emil W Ciurczak, Cindy Tso, Stacy A MacDonald.   

Abstract

It is possible to devise calibration and validation protocols that enable the ICH guidelines to conform to the specialized requirements of the NIR method of analysis. Some of the required characteristics of evaluation specified by the guidelines, such as accuracy and repeatability, can be applied directly, just as with any other analytical method. Other characteristics are adapted through the novel use of specialized statistics, or through the use of creative methods and procedures to match the recommendations of the guidelines to the unique and specialized requirements of the NIR method.

Entities:  

Mesh:

Year:  2002        PMID: 11929667     DOI: 10.1016/s0731-7085(01)00567-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Blend uniformity analysis using stream sampling and near infrared spectroscopy.

Authors:  Manuel Popo; Saly Romero-Torres; Carlos Conde; Rodolfo J Romañach
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

2.  Evaluation of the conformity index and the Mahalanobis distance as a tool for process analysis: a technical note.

Authors:  Gary E Ritchie; Howard Mark; Emil W Ciurczak
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

3.  Quantitation of drug content in a low dosage formulation by transmission near infrared spectroscopy.

Authors:  Carlos Peroza Meza; María A Santos; Rodolfo J Romañach
Journal:  AAPS PharmSciTech       Date:  2017-03-08       Impact factor: 3.246

4.  Application of NIR spectroscopy for the quality control of mangosteen pericarp powder: quantitative analysis of alpha-mangostin in mangosteen pericarp powder and capsule.

Authors:  Jomjai Peerapattana; Kuniko Otsuka; Makoto Otsuka
Journal:  J Nat Med       Date:  2012-08-25       Impact factor: 2.343

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.